Saturday, August 18, 2018
Company News: Page (1) of 1 - 08/09/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Dave Harris Joins Avadyne Health's Board of Directors
(August 09, 2018)

MOLINE, Ill., Aug. 9, 2018 /PRNewswire/ -- Avadyne Health, a patient liability resolution expert and WindRose Health Investors, formerly MTS Health Investors, today announced Dave Harris, a recently retired principle at PricewaterhouseCoopers (PwC), has been appointed to the Avadyne Health Board of Directors. 

"Dave is an accomplished leader and pioneer in the healthcare payments field and a contributor in building one of the largest revenue cycle consulting practices during his 25 years at PwC," said Jayson Yardley, CEO of Avadyne Health.

"We're delighted to welcome Dave to the Board and look forward to his contributions," said Curtis Lane, Founding Partner of WindRose Health Investors. "Drawing on his years of experience in healthcare, Dave will provide fresh insights to our business priorities," he added.

"I am honored to serve on Avadyne Health's Board of Directors," said Dave Harris. "The company is transforming patient liability resolution and patient satisfaction with market-leading solutions, engagement concierges and innovative technologies. Their focus on reducing the cost-to-collect and improving patient satisfaction are game changers in today's market."

Prior to PwC, Harris formerly served in leadership roles at Ernst & Young, Deloitte, EDS and IBM.  He's consulted a variety of healthcare payers and providers on their payment platforms.  He assisted in the development of the first national claims processing system, still in use today. Harris was a founding member of the American Hospital Association (AHA) and participated in the patient-friendly billing initiative with Healthcare Financial Management Association (HFMA).

As a management consultant, he has helped payers, providers and clearinghouses improve operations, optimize systems, co-source/outsource and consolidate business office functions.  He considers himself a life-long advocate of healthcare business office professionals who are under constant pressure to collect money.

Harris holds a Master of Business Administration and an undergraduate degree from Oregon State University. Now retired, he and his wife Kathleen live bicoastal, raising their family of four children in New Jersey and starting a farm in Oregon's Willamette Valley.

About Avadyne Health: 
As a leading 47-year patient liability resolution expert serving 275 healthcare providers and collecting nearly $1 billion in patient payments annually, Avadyne Health is a leader in reducing the cost to collect, increasing patient liability resolution and improving patient satisfaction. Services include Financial Clearance, Self-Pay Account Resolution and Bad Debt Recovery. Learn more about how Avadyne's market-leading solutions, patient engagement concierges and innovative technologies, such as Patient Concierge, ePFXpatientportal, ePFXsolutions and ePFXscore, deliver impactful financial outcomes and improve patient satisfaction. Contact or visit us at

About WindRose Health Investors:
WindRose Health Investors, formerly MTS Health Investors, makes equity investments in companies that operate within the services sectors of the healthcare industry. WindRose Health Investors focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions.  WindRose Health Investors manages over $700 million of capital and is currently investing out of its fourth fund. WindRose Health Investors is based in New York City and invests in companies throughout the United States. For more information, please email us at [email protected].

Contact: Christine Ehlinger
Director of Marketing
[email protected] 
P: 619-819-0626

Cision View original content with multimedia:

SOURCE Avadyne Health

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Business,Email,Family,Children,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines